Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Multiple Endocrine Neoplasia Type 2, Deletions-Duplications (MLPA) RET Gene Reference Laboratory Genetics Spain | 2 | 1 |
|
Multiple Endocrine Neoplasia Type 2B, Sequencing Exons (15,16) RET Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Comprehensive Hereditary Cancer Panel Baylor Genetics United States | 132 | 61 |
|
Hereditary Endocrine Cancer Panel Baylor Genetics United States | 51 | 15 |
|
Hereditary Paraganglioma/Pheochromocytoma Panel Baylor Genetics United States | 21 | 9 |
|
Institute of Human Genetics Cologne University Germany | 17 | 11 |
|
Multiple endocrine neoplasia, type 2 Labor Dr. Wisplinghoff Germany | 2 | 1 |
|
Molecular Vision Laboratory United States | 19 | 7 |
|
Invitae Pediatric Solid Tumors Panel Invitae United States | 90 | 48 |
|
Paraganglioma-Pheochromocytoma Comprehensive Panel Fulgent Genetics United States | 29 | 11 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Thyroid Cancer Comprehensive Panel Fulgent Genetics United States | 37 | 7 |
|
Comprehensive Hereditary Cancer Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 128 | 130 |
|
Hereditary Paraganglioma/Pheochromocytoma Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 9 | 12 |
|
Invitae United States | 23 | 7 |
|
Invitae Hyperparathyroidism Panel Invitae United States | 9 | 5 |
|
Invitae United States | 139 | 80 |
|
Invitae Multiple Endocrine Neoplasia Type 2 Test Invitae United States | 6 | 1 |
|
Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University United States | 33 | 49 |
|
RET Gene Sequencing and Deletion/Duplication Analysis DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children United States | 8 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.